Over the next 5 years, Gland Pharma plans to invest approximately Rs 20 bn in capex, primarily towards BFS and ophthalmic lines as well as capex towards CDMO contracts. Brownfield expansions will ...

Aspire Biopharma’s new sublingual powder bypasses digestion, delivering alprazolam directly for faster anxiety and panic ...

NPPA asks Bayer Zydus Pharma to continue selling Urografin for one more year: Gireesh Babu, New Delhi Thursday, March 5, 2026, 08:00 Hrs [IST] The National Pharmaceutical Pricing ...

Unither is an independent pharmaceutical company specialising in the development and contract manufacture of the pharmaceutical formulations that patients ...

Astorg, EQT, New Mountain Capital and TA Associates are among the PE firms buying and selling active pharmaceutical ingredient assets.

Semaglutide has already become more than just a “vanity drug.” Clinical trials like SUSTAIN-6 and FLOW have shown it can slash the risk of kidney disease, reduce major heart attacks, and even lower ...

CDSCO asks stakeholders to submit application for prior intimation in line with recent NDCT Rules amendment: Gireesh Babu, ...

Elara Capital initiates coverage with 'Buy' rating and ₹775 target, citing stronger earnings cycle, US formulations growth and margin expansion.

South Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic ...

South Africa's National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country.

The S&P Global Corporate Sustainability Assessment—one of the world’s most comprehensive ESG benchmarks—evaluates companies on industry-specific economic, environmental, and social criteria. Lupin has ...

Forma Life Sciences, which inherited BioDuro’s California production operations earlier this year, has officially ...